<DOC>
	<DOCNO>NCT01848717</DOCNO>
	<brief_summary>The objective clinical test verify safety efficacy MINTLIFT® , use purpose improve appearance nasolabial fold side face .</brief_summary>
	<brief_title>Evaluate Efficacy Safety MINTLIFT® Group Nasolabial Fold</brief_title>
	<detailed_description />
	<criteria>Individuals desire improvement appearance nasolabial fold side face score 3 4 Wrinkle Severity Rating Scale ( WSRS ) time screen baseline time point Individuals consent abstain dermatological procedure treatment , include treatment wrinkle reduction facial area , duration clinical test Subjects scar hypertrophic scar history keloid condition may affect determination effect Subjects allergic local anesthetic sleep anesthetic Subjects whose ALT/AST ratio 2.5 time great normal upper limit Subjects administer anticoagulant ( exception low dosage aspirin ( 100mg , 300mg/day ) ) within 2 week date screening , require anticoagulant period clinical test Subjects administer systemic corticosteroid anabolic steroid within two week date screen require administration period clinical test ( note , however , administration inhale corticosteroid standardize dosage permissible ) Subjects administer Vitamin E nonsteroidal antiinflammatory drug within 1 week date screening Subjects use Topical liniment facial area ( steroid , retinoids : medical drug include criterion , exclusion cosmetic product ) within 4 week date screening plan continue usage period clinical test Subjects receive wrinkle reduction treatment use CaHA within 1 year date screening Subjects receive wrinkle reduction treatment use collagen HA filler within 6 month date screening , receive acne treatment , skin regeneration procedure , cosmetic surgical procedure ( include Botox injection ) facial area Subjects permanent skin expand implant Softform silicon insert facial area Subjects scar facial area require treatment heal period 1 year longer , scar trace area clinical test device apply . Subjects chronic recurrent infection history inflammatory disease may affect clinical test Subjects experience severe allergy symptom anaphylaxis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>